Literature DB >> 30056585

Correction of cicatricial ectropion using non-ablative fractional laser resurfacing.

Fabio Nicoli1,2,3,4, Georgios Orfaniotis5,6, Pedro Ciudad6, Michele Maruccia6, Davide Lazzeri7,8, Lorenzo Costabile9, Ke Li10, Yi Xin Zhang8, Valerio Cervelli11, Alberto Balzani11.   

Abstract

Lower eyelid malposition is the most frequent and severe complication after blepharoplasty and ectropion is observed in 1% of patients after surgery. This article describes a non-surgical method to treat lower eyelid cicatricial ectropion using a non-ablative laser as an alternative to surgery. Twelve patients with unilateral or bilateral lower lid cicatricial ectropion, following surgery or trauma, underwent laser therapy from 2012 to 2016. Laser therapy was performed with a fractional non-ablative laser emitting at a wavelength of 1540 nm. Ten patients had a full correction of their ectropion and two patients had a partial recovery after laser therapy at 6-month follow-up visit. No serious adverse events were reported. Non-ablative fractional laser resurfacing can successfully treat cicatricial ectropion by remodeling the periocular scar tissue and improving the scar texture, and as such may be considered as a valuable alternative to surgery in selected patients.

Entities:  

Keywords:  Blepharoplasty; Ectropion, laser, 1540, eyelid; Non-ablative laser

Mesh:

Year:  2018        PMID: 30056585     DOI: 10.1007/s10103-018-2601-y

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  26 in total

1.  An alternative approach for involutional entropion: a preliminary study.

Authors:  Orhan Babuccu
Journal:  Lasers Med Sci       Date:  2011-12-14       Impact factor: 3.161

2.  Skin responses to fractional photothermolysis.

Authors:  Hans-Joachim Laubach; Zeina Tannous; R Rox Anderson; Dieter Manstein
Journal:  Lasers Surg Med       Date:  2006-02       Impact factor: 4.025

3.  Management of lower lid ectropion.

Authors:  Jutta Liebau; Andrea Schulz; Andreas Arens; Hubertus Tilkorn; Volker Schwipper
Journal:  Dermatol Surg       Date:  2006-08       Impact factor: 3.398

Review 4.  Use of hyaluronic acid gel in the management of cicatricial ectropion: results and complications.

Authors:  Ricardo Romero; Margarita Sanchez-Orgaz; Maria Granados; Alvaro Arbizu; Ananda Castano; Ana Romero; Pilar Molia
Journal:  Orbit       Date:  2013-09-24

5.  The prevention and treatment of lower lid ectropion following blepharoplasty.

Authors:  J H Carraway; C G Mellow
Journal:  Plast Reconstr Surg       Date:  1990-06       Impact factor: 4.730

Review 6.  Complications of blepharoplasty.

Authors:  Serge Morax; Valerie Touitou
Journal:  Orbit       Date:  2006-12

7.  Minor complications after blepharoplasty: dry eyes, chemosis, granulomas, ptosis, and scleral show.

Authors:  Salvatore J Pacella; Mark A Codner
Journal:  Plast Reconstr Surg       Date:  2010-02       Impact factor: 4.730

8.  Treatment of extrinsic ectropion on burned face with facial suspension technique.

Authors:  Luiz Philipe Molina Vana; Cesar Isaac; Nivaldo Alonso
Journal:  Burns       Date:  2014-07-03       Impact factor: 2.744

9.  Nonsurgical treatment of cicatricial ectropion with hyaluronic acid filler.

Authors:  John P Fezza
Journal:  Plast Reconstr Surg       Date:  2008-03       Impact factor: 4.730

Review 10.  Current progress in understanding the molecular pathogenesis of burn scar contracture.

Authors:  Jianglin Tan; Jun Wu
Journal:  Burns Trauma       Date:  2017-05-22
View more
  2 in total

1.  Laser Resurfacing for the Management of Periorbital Scarring.

Authors:  Nathan Pirakitikulr; John J Martin; Sara T Wester
Journal:  Plast Aesthet Res       Date:  2020-11-20

2.  Treatment of hypertrophic scars and keloids using an intralesional 1470 nm bare-fibre diode laser: a novel efficient minimally-invasive technique.

Authors:  Ke Li; Fabio Nicoli; Chunxiao Cui; Wen Jing Xi; Ahmed Al-Mousawi; Zheng Zhang; Alberto Balzani; Lindsay Neill; Roberto Sorge; Yun Tong; Yixin Zhang
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.